Iovance Biotherapeutics Inc (IOVA)
11.79
+0.02
(+0.17%)
USD |
NASDAQ |
May 01, 10:06
Iovance Biotherapeutics Profit Margin (Quarterly): -24.15K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -24.15K% |
September 30, 2023 | -24.26K% |
Date | Value |
---|---|
June 30, 2023 | -44.76K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-44.76K%
Minimum
Jun 2023
-24.15K%
Maximum
Dec 2023
-31.05K%
Average
-24.26K%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
QuidelOrtho Corp | 0.94% |
Perspective Therapeutics Inc | -- |
Electromed Inc | 12.23% |
Xtant Medical Holdings Inc | -15.31% |
Asensus Surgical Inc | -317.3% |
Profit Margin (Quarterly) Related Metrics
Gross Profit Margin (Quarterly) | -805.6% |
Operating Margin (Quarterly) | -25.16K% |